Search
V591
go.drugbank.com/drugs/DB16438InvestigationalThrough Merck’s acquisition of Thermis in May 2020, they were able to leverage Thermis’ platform knowledge and accelerate the development of V591 to phase I clinical trials (NCT04498247)[L30593]. … The V591 vaccine, part of Merck’s COVID-19 vaccine programming, was developed using a modified measles vaccine virus as a vector for COVID-19 antigen delivery[L30593].
α-Methylacetylfentanyl
go.drugbank.com/drugs/DB01532ExperimentalIllicitα-Methylacetylfentanyl is an analog of fentanyl with opioid analgesic properties. … anhydride for the production of chemical propionic anhydride in the synthesis.
Conteltinib
go.drugbank.com/drugs/DB21262InvestigationalConteltinib has a monoisotopic molecular weight of 635.34 Da. … The usage of the INN stem '-tinib' in the name indicates that Conteltinib is a tyrosine kinase inhibitor.
MB07811
go.drugbank.com/drugs/DB05192InvestigationalMB07811 is the first of a novel class of product candidates discovered by Metabasis designed to lower serum cholesterol and triglycerides. … The combination of selectivity for the beta form of the receptor, liver targeting and other structural characteristics that limit extra-hepatic activity is designed to provide significant efficacy while
(S)-Warfarin
go.drugbank.com/drugs/DB14055InvestigationalWarfarin consists of a racemic mixture of two active enantiomers—R- and S- forms—each of which is cleared by different pathways.
Glucose-6-Phosphate
go.drugbank.com/drugs/DB03581ExperimentalAn ester of glucose with phosphoric acid, made in the course of glucose metabolism by mammalian and other cells. … It is a normal constituent of resting muscle and probably is in constant equilibrium with fructose-6-phosphate. (Stedman, 26th ed)
Ebaresdax
go.drugbank.com/drugs/DB21496InvestigationalEbaresdax has a monoisotopic molecular weight of 266.07 Da. … Ebaresdax is under investigation in clinical trial NCT05008835 (Evaluate the Efficacy and Safety of ACP-044 in Subjects With Pain Associated With Osteoarthritis of the Knee).
Razpipadon
go.drugbank.com/drugs/DB21542InvestigationalRazpipadon has a monoisotopic molecular weight of 389.12 Da. … Razpipadon is under investigation in clinical trial NCT04958031 (A Trial of the Safety, Tolerability, and Pharmacodynamics of CVL-871 in Subjects With Dementia-Related Apathy).
Barzuxetan
go.drugbank.com/drugs/DB21132ExperimentalThe usage of the INN stem '-xetan' in the name indicates that Barzuxetan is a chelating agent. Barzuxetan has a monoisotopic molecular weight of 594.2 Da.
Timtraxanib
go.drugbank.com/drugs/DB21515ExperimentalThe usage of the INN stem '-anib' in the name indicates that Timtraxanib is a angiogenesis inhibitor. Timtraxanib has a monoisotopic molecular weight of 621.31 Da.